对新诊断的炎症性关节炎进行自我管理干预的效果:随机对照试验的研究方案
Luise Holberg Lindgren1, Tanja Thomsen2,3, Merete Lund Hetland2,4
1Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Centre for Head and Orthopedics, Rigshospitalet, Glostrup, Denmark. luise.holberg.lindgren@regionh.dk.
Trials
|November 28, 2025
概括
这项研究测试了早期炎症性关节炎患者的新诊断的炎症性关节炎 - 自主管理干预 (NISMA). 尼斯玛显示出提高自我管理技能的潜力,提供了一种新的非药物治疗方法.
科学领域:
- 类风湿病学 类风湿病学
- 临床试验 临床试验
- 医疗保健服务研究 医疗服务研究
背景情况:
- 新诊断的炎症性关节炎 (IA) 带来了重大的身体,心理和社会挑战.
- 目前的药理疗法不能完全满足这些多方面的患者需求.
- 需要有效的非药物干预措施来支持患者在疾病发展的早期.
研究的目的:
- 评估"新诊断的炎症性关节炎 - 自主管理干预" (NISMA) 与单独的通常护理相比的疗效.
- 评估NISMA对新诊断的类风湿性关节炎,牛皮性关节炎或轴性脊髓关节炎患者的技能和技术学习的影响.
- 为提升早期IA的非药物管理提供见解.
主要方法:
- 一个务实的,多中心随机对照试验 (RCT) 涉及130名成年人新诊断的IA.
- 参与者被随机分配1:1接受NISMA加常规护理或仅接受常规护理.
- NISMA干预包括护士领导的12个月的个人和小组会议,主要结果在12个月后使用heQ"技能和技术获取"领域进行评估.
主要成果:
- 主要分析将使用ANCOVA调整到基线,中心和诊断.
- 治疗意图原则将指导分析,对缺少的数据进行多次归算.
- 二级终点将被分层评估,使用线性混合效应模型进行24个月的延期分析.
结论:
- NISMA RCT将为早期IA提供关键数据,用于针对性自我管理计划的有效性.
- 成功实施NISMA可以显著改善非药物管理策略.
- 这种干预可以提供一种全面的方法来解决新诊断的IA患者的身体和心理需求.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
450
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
450
Rheumatic Heart Disease III: Medical Management
267
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
267
Atherosclerosis III: Management
296
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
296
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
617
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
617
Inflammatory Bowel Disease V: Surgical Management
428
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
428
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
461
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
461


